Cardiac allograft vasculopathy screening: Difference between revisions
| Line 7: | Line 7: | ||
==Screening== | ==Screening== | ||
The 2010 International Society of Heart and Lung Transplant Guidelines for the care of heart transplant recipients recommend annual invasive coronary angiography as the screening tool of choice for CAV.<ref name="pmid20643330">{{cite journal| author=Costanzo MR, Dipchand A, Starling R, Anderson A, Chan M, Desai S et al.| title=The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. | journal=J Heart Lung Transplant | year= 2010 | volume= 29 | issue= 8 | pages= 914-56 | pmid=20643330 | doi=10.1016/j.healun.2010.05.034 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20643330 }} </ref> | The 2010 International Society of Heart and Lung Transplant Guidelines for the care of heart transplant recipients recommend annual invasive coronary angiography as the screening tool of choice for CAV.<ref name="pmid20643330">{{cite journal| author=Costanzo MR, Dipchand A, Starling R, Anderson A, Chan M, Desai S et al.| title=The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. | journal=J Heart Lung Transplant | year= 2010 | volume= 29 | issue= 8 | pages= 914-56 | pmid=20643330 | doi=10.1016/j.healun.2010.05.034 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20643330 }} </ref> In most centers screening of graft coronary arteries for signs of CAV is usually performed six weeks after cardiac transplantation and then annually thereafter. | ||
==References== | ==References== | ||
Revision as of 15:14, 27 July 2014
|
Cardiac allograft vasculopathy Microchapters |
|
Differentiating Cardiac allograft vasculopathy from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Cardiac allograft vasculopathy screening On the Web |
|
American Roentgen Ray Society Images of Cardiac allograft vasculopathy screening |
|
Directions to Hospitals Treating Cardiac allograft vasculopathy |
|
Risk calculators and risk factors for Cardiac allograft vasculopathy screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2] Raviteja Guddeti, M.B.B.S. [3]
Overview
In most cardiac transplant centers coronary angiography currently remains the screening tool of choice for cardiac allograft vasculopathy (CAV).
Screening
The 2010 International Society of Heart and Lung Transplant Guidelines for the care of heart transplant recipients recommend annual invasive coronary angiography as the screening tool of choice for CAV.[1] In most centers screening of graft coronary arteries for signs of CAV is usually performed six weeks after cardiac transplantation and then annually thereafter.
References
- ↑ Costanzo MR, Dipchand A, Starling R, Anderson A, Chan M, Desai S; et al. (2010). "The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients". J Heart Lung Transplant. 29 (8): 914–56. doi:10.1016/j.healun.2010.05.034. PMID 20643330.